To screen the specific biomarkers of hepatocellular carcinoma (HCC) through multi‑dimensional analysis of bioinformatics and explore their diagnostic and prognostic value.
Methods
2
The HCC dataset GSE136247 from the GEO database and the gene expression data related to liver cancer from the TCGA database were downloaded. The R package edgeR was used to analyze the differential expression genes (DEGs) of the data from the two cohorts separately and the intersection was taken. DEGs were subsequently enriched and functionally annotated based on GO
KEGG
Reactive
and WikiPathway databases. The protein⁃protein interaction (PPI) network based on DEGs was constructed by the STRING database
and the key genes in the PPI network were obtained by Cytoscape software. GEPIA database
HPA database
and the GEO additional data cohort were used to verify the expression of key genes
and the stepwise regression method was used to screen the key genes to construct the Cox model of liver cancer prognosis
and binary logistic regression was used to construct the diagnostic model. The Nomogram was drawn by the R package rms
and the Timer algorithm of the R package IOBR was used to explore the association between core genes and immune infiltration. The R package clusterProfiler was used for the GSEA analysis of core genes. Spearman correlation analysis was used to analyze the association between core genes and immune checkpoint genes. The R package oncoPredict explores the drug associations of core genes.
Results
2
A total of 432 DEGs and 15 key genes were identified in HCC and adjacent tissues. Two high‑risk molecules
CCT3
and
KPNA2
were screened out by a series of bioinformatics analysis methods
and a bi‑molecular Cox model was constructed. The bimolecular Cox model score and tumor stage are independent clinical risk assessment indicators
and the risk model has value in predicting the 1‑
3‑
5‑
and 7‑year prognosis of patients. At the same time
the prognosis predicted by the Nomogram was in good agreement with the actual prognosis. In addition
the bimolecular logistic regression model could effectively distinguish cancer from non‑cancer (
AUC
>
0.95). Immune correlation analysis showed that the expression of
CCT3
and
KPNA2
was significantly correlated with the level of immune cell infiltration. GSEA analysis showed that
CCT3
a
nd
KPNA2
were mainly enriched in E2F‑TARGETS and G2M‑checkpoints. Immune checkpoint correlation analysis showed that
CCT3
and
KPNA2
were the most correlated with CD276.
Conclusion
2
CCT3
and
KPNA2
are HCC‑specific biomarkers successfully screened in this study. The bi‑molecular logistic regression diagnostic model
Cox risk model
and Nomogram can be effectively used for HCC diagnosis and prognosis prediction.
关键词
Keywords
references
ZHOU J , SUN H C , WANG Z , et al . Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition) [J ] . Liver Cancer , 2023 , 12 ( 5 ): 405 ‑ 444 .
AIZARANI N , SAVIANO A , SAGAR , et al . A human liver cell atlas reveals heterogeneity and epithelial progenitors [J ] . Nature , 2019 , 572 ( 7768 ): 199 ‑ 204 .
SU T , ZHANG N S , WANG T , et al . Super enhancer‑regulated LncRNA LINC01089 induces alternative splicing of DIAPH 3 to drive hepatocellular carcinoma metastasis [J ] . Cancer Res , 2023 , 83 ( 24 ): 4080 ‑ 4094 .
SELÇUK H . Prognostic factors and staging systems in hepatocellular carcinoma [J ] . Exp Clin Transplant , 2017 , 15 ( Suppl 2 ): 45 ‑ 49 .
GROHMANN M , WIEDE F , DODD G T , et al . Obesity drives STAT‑1‑dependent NASH and STAT‑3‑dependent HCC [J ] . Cell , 2018 , 175 ( 5 ): 1289 ‑ 1306.e20 .
PROKOP J W , MAY T , STRONG K , et al . Genome sequencing in the clinic: The past, present, and future of genomic medicine [J ] . Physiol Genomics , 2018 , 50 ( 8 ): 563 ‑ 579 .
CHEN C T , CHEN C F , LIN T Y , et al . Traditional Chinese medicine Kuan‑Sin‑Yin Decoction inhibits cell mobility via downregulation of CCL2, CEACAM1 and PIK3R3 in hepatocellular carcinoma cells [J ] . J Ethnopharmacol , 2023 , 317 : 116834 .
SHAHINI E , PASCULLI G , SOLIMANDO A G , et al . Updating the clinical application of blood biomarkers and their algorithms in the diagnosis and surveillance of hepatocellular carcinoma: A critical review [J ] . Int J Mol Sci , 2023 , 24 ( 5 ): 4286 .
ZHOU J M , XU W Q , WU Y B , et al . GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway [J ] . Oncogene , 2023 , 42 ( 45 ): 3319 ‑ 3330 .
LI B H , CAO Y J , MENG G , et al . Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta‑catenin pathway [J ] . EBioMedicine , 2019 , 39 : 239 ‑ 254 .
LIU Z Y , LI Y N , WANG Y F , et al . Exosomes in HBV infection [J ] . Clin Chim Acta , 2023 , 538 : 65 ‑ 69 .
CUI X , HU Z P , LI Z , et al . Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma [J ] . World J Gastroenterol , 2015 , 21 ( 28 ): 8588 ‑ 8604 .
LIU Y , ZHANG X , LIN J F , et al . CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer [J ] . Cell Death Dis , 2019 , 10 ( 9 ): 644 .
QIAN E N , HAN S Y , DING S Z , et al . Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma [J ] . Cancer Cell Int , 2016 , 16 : 55 .
GUO X G , WANG Z H , ZHANG J N , et al . Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types [J ] . Acta Biochim Biophys Sin , 2019 , 51 ( 3 ): 285 ‑ 292 .
HERRERA‑LÓPEZ E E , GUERRERO‑ESCALERA D , AGUIRRE‑MALDONADO I , et al . Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis [J ] . Sci Rep , 2023 , 13 ( 1 ): 6948 .
WANG H K , LIANG J F , ZHENG H X , et al . Expression and prognostic significance of ECT2 in invasive breast cancer [J ] . J Clin Pathol , 2018 , 71 ( 5 ): 442 ‑ 445 .
BAI X G , YI M , XIA X C , et al . Progression and prognostic value of ECT2 in non‑small‑cell lung cancer and its correlation with PCNA [J ] . Cancer Manag Res , 2018 , 10 : 4039 ‑ 4050 .
XU D F , WANG Y , WU J C , et al . ECT2 overexpression promotes the polarization of tumor‑associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway [J ] . Cell Death Dis , 2021 , 12 ( 2 ): 162 .
MENG J , WANG L H , HOU J , et al . CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop [J ] . Cancer Sci , 2021 , 112 ( 8 ): 3099 ‑ 3110 .
CHANDRA R , KARALIS J D , LIU C , et al . The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis [J ] . Cancers , 2021 , 13 ( 24 ): 6206 .
LI W L , LIU J , ZHAO H T . Prognostic power of a chaperonin containing TCP‑1 subunit genes panel for hepatocellular carcinoma [J ] . Front Genet , 2021 , 12 : 668871 .
LIU X H , LI Z J , LI K , et al . Expression and clinical significance of nuclear transporter alpha‑2 in hepatocellular carcinoma [J ] . Chin J LAB Surgery , 2022 , 39 ( 10 ): 1848 ‑ 1852 .
FENG Y , LEE J , YANG L P , et al . Engineering CD276/B7‑H3‑targeted antibody‑drug conjugates with enhanced cancer‑eradicating capability [J ] . Cell Rep , 2023 , 42 ( 12 ): 113503 .
Expression of LncRNA‑TMEM220‑AS1 in hepatocellular carcinoma and its effect on cell proliferation and invasiveness
Development and validation of a prognosis model for hepatocellular carcinoma based on immune related genes
Bioinformatics prediction and expression analysis of tumor suppressor LHPP in hepatocellular carcinoma
Exploring the differences between CASIA2 and Pentacam in preoperative evaluation of cataracts: A comparison based on measurements of anterior chamber volume, corneal thickness, and pupil diameter
Repetitive transcranial magnetic stimulation improves synaptic ultrastructure in a mouse model of Alzheimer's disease
Related Author
CHEN Yiyi
RONG Yuan
REN Chao
YE Mingliang
HONG Yinghui
LIU Jialiang
WANG Chun
KANG Hui
Related Institution
Dept. of Gastroenterology, Zhongnan Hospital of Wuhan University; Hubei Clinical Center of Intestinal and Colorectal Diseases; &Hubei Key Laboratory of Intestinal and Colorectal Diseases
Dept. of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University
Dept.of Gastroenterology, Renmin Hospital of Wuhan University
Zhongnan Hospital of Wuhan University; Institute of Hepatobiliary Diseases of Wuhan University & Transplant Center of Wuhan University
National Quality Control Center for Donated Organ Procurement; Hubei Key Laboratory of Medical Technology on Transplantation & Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver